
Inocras is a bioinformatics-led company redefining precision health through whole genome data and proprietary analytics. Our oncology and rare disease platforms integrate comprehensive whole genome data with advanced automation to deliver curated and actionable insights at scale that accelerate discovery and diagnostics to improve patient care, bringing a real-world impact.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 08/05/26 | $31,000,000 | Series B-3 |
Aimed Bio DSC Investment Dunamu & Partners IMM Investment InterVest Korea Investment Partners LoftyRock Investment NDS Corporation | undisclosed |